BOSTON SCIENTIFIC CORP (1BSX.MI) Stock Price, Quote, News and Overview
BIT:1BSX - Euronext Milan - US1011371077 - Common Stock - Currency: EUR
1BSX.MI Quote, Performance and Key Statistics
BIT:1BSX (3/7/2025, 7:00:00 PM)
90.5
+6.5 (+7.74%)
The current stock price of 1BSX.MI is 90.5 EUR.
1BSX.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 29.15 | 217.38B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
| 2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
| BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
| 1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
| DC4.DE | DEXCOM INC | 48.5 | 28.81B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 18.17 | 23.74B |
Related stock screener links
About 1BSX.MI
Company Profile
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 48,000 full-time employees. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. The company also owns the transcarotid artery revascularization (TCAR) platform.
Company Info
BOSTON SCIENTIFIC CORP
300 Boston Scientific Way
Marlborough MASSACHUSETTS US
Employees: 48000
Company Website: https://www.bostonscientific.com/en-US/Home.html
Investor Relations: https://investors.bostonscientific.com
Phone: 15086834000
BOSTON SCIENTIFIC CORP / 1BSX.MI FAQ
What is the stock price of BOSTON SCIENTIFIC CORP today?
The current stock price of 1BSX.MI is 90.5 EUR. The price increased by 7.74% in the last trading session.
What is the ticker symbol for BOSTON SCIENTIFIC CORP stock?
The exchange symbol of BOSTON SCIENTIFIC CORP is 1BSX and it is listed on the Euronext Milan exchange.
On which exchange is 1BSX.MI stock listed?
1BSX.MI stock is listed on the Euronext Milan exchange.
What is the price forecast or stock price prediction for BOSTON SCIENTIFIC CORP stock?
38 analysts have analysed 1BSX.MI and the average price target is 97.45 EUR. This implies a price increase of 7.67% is expected in the next year compared to the current price of 90.5. Check the BOSTON SCIENTIFIC CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BOSTON SCIENTIFIC CORP worth?
BOSTON SCIENTIFIC CORP (1BSX.MI) has a market capitalization of 133.38B EUR. This makes 1BSX.MI a Large Cap stock.
How many employees does BOSTON SCIENTIFIC CORP have?
BOSTON SCIENTIFIC CORP (1BSX.MI) currently has 48000 employees.
Is BOSTON SCIENTIFIC CORP (1BSX.MI) expected to grow?
The Revenue of BOSTON SCIENTIFIC CORP (1BSX.MI) is expected to grow by 17.61% in the next year. Check the estimates tab for more information on the 1BSX.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BOSTON SCIENTIFIC CORP (1BSX.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1BSX.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1BSX.MI, evaluating the profitability, health, valuation and growth aspects
- BOSTON SCIENTIFIC CORP (1BSX.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BOSTON SCIENTIFIC CORP (1BSX.MI) Sales and EPS estimates to see what analysts future expectations are.
- BOSTON SCIENTIFIC CORP (1BSX.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BOSTON SCIENTIFIC CORP (1BSX.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- BOSTON SCIENTIFIC CORP (1BSX.MI) Stock Chart to make your own analysis
- BOSTON SCIENTIFIC CORP (1BSX.MI) Latest news and press-releases to stay up to date.
Does BOSTON SCIENTIFIC CORP (1BSX.MI) stock pay dividends?
1BSX.MI does not pay a dividend.
When does BOSTON SCIENTIFIC CORP (1BSX.MI) report earnings?
BOSTON SCIENTIFIC CORP (1BSX.MI) will report earnings on 2025-02-05, after the market close.
What is the Price/Earnings (PE) ratio of BOSTON SCIENTIFIC CORP (1BSX.MI)?
The PE ratio for BOSTON SCIENTIFIC CORP (1BSX.MI) is 39.52. This is based on the reported non-GAAP earnings per share of 2.29 and the current share price of 90.5 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1BSX.MI.
1BSX.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1BSX.MI.
1BSX.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1BSX.MI. Both the profitability and the financial health of 1BSX.MI get a neutral evaluation. Nothing too spectacular is happening here.
1BSX.MI Financial Highlights
Over the last trailing twelve months 1BSX.MI reported a non-GAAP Earnings per Share(EPS) of 2.29. The EPS increased by 18.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.27% | ||
| ROA | 4.71% | ||
| ROE | 8.66% | ||
| Debt/Equity | 0.45 |
1BSX.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to 1BSX.MI. The Buy consensus is the average rating of analysts ratings from 38 analysts.
For the next year, analysts expect an EPS growth of 21.26% and a revenue growth 17.61% for 1BSX.MI